Skip navigation
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.unb.br/handle/10482/28307
Ficheros en este ítem:
Fichero Tamaño Formato  
ARTIGO_HansensDiseaseVanishing.pdf471,52 kBAdobe PDFVisualizar/Abrir
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorTalhari, Sinésiopt_BR
dc.contributor.authorGrossi, Maria Aparecida de Fariapt_BR
dc.contributor.authorOliveira, Maria Leide W. D. R. dept_BR
dc.contributor.authorGontijo, Bernardopt_BR
dc.contributor.authorTalhari, Carolinapt_BR
dc.contributor.authorPenna, Gerson Oliveirapt_BR
dc.date.accessioned2017-12-07T04:58:14Z-
dc.date.available2017-12-07T04:58:14Z-
dc.date.issued2012pt_BR
dc.identifier.citationTALHARI, Sinésio et al. Hansen's disease: a vanishing disease?. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 107, supl. 1, p. 13-16, dez. 2012. DOI: https://doi.org/10.1590/S0074-02762012000900003. Disponível em: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000900003&lng=en&tlng=en. Acesso em: 26 out. 2020.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/28307-
dc.language.isoenpt_BR
dc.publisherInstituto Oswaldo Cruz, Ministério da Saúdept_BR
dc.rightsAcesso Abertopt_BR
dc.titleHansen's disease : a vanishing disease?pt_BR
dc.typeArtigopt_BR
dc.subject.keywordHanseníasept_BR
dc.subject.keywordHanseníase - tratamentopt_BR
dc.rights.licenseMemórias do Instituto Oswaldo Cruz - (CC BY-NC) All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Fonte: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000900003&lng=en&tlng=en. Acesso em: 26 out. 2020.-
dc.identifier.doihttps://dx.doi.org/10.1590/S0074-02762012000900003pt_BR
dc.description.abstract1The introduction, implementation, successes and failures of multidrug therapy (MDT) in all Hansen's disease endemic countries are discussed in this paper. The high efficacy of leprosy treatment with MDT and the global reduction of prevalence led the World Health Organization, in 1991, to establish the goal of elimination of Hansen's disease (less than 1 patient per 10,000 inhabitants) to be accomplished by the year 2000. Brazil, Nepal and East Timor are among the few countries that didn't reach the elimination goal by the year 2000 or even 2005. The implications of these aspects are highlighted in this paper. Current data from endemic and previously endemic countries that carry a regular leprosy control programme show that the important fall in prevalence was not followed by the reduction of the incidence. This means that transmission of Mycobacterium leprae is still an issue. It is reasonable to conclude that we are still far from the most important goal of Hansen's disease control: the interruption of transmission and reduction of incidence. It is necessary to emphasize to health managers the need of keeping Hansen's disease control activities to better develop control programmes in the future. The recent international proposal to interrupt the transmission of leprosy by the year 2020 seems to unrealistic and it is discussed in this paper. The possibility of epidemiological impact related to the human immunodeficiency virus/Hansen's disease coinfection is also considered.-
dc.description.unidadeFaculdade de Medicina (FM)-
Aparece en las colecciones: Artigos publicados em periódicos e afins

Mostrar el registro sencillo del ítem " class="statisticsLink btn btn-primary" href="/handle/10482/28307/statistics">



Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.